High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder
<h3>Introduction</h3><p dir="ltr">Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by defects in two core domains, social/communication skills and restricted/repetitive behaviors or interests. There is no approved biomarker for ASD diagnosis,...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , , , , , , |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1864513507603513344 |
|---|---|
| author | Areej Mesleh (17149822) |
| author2 | Hanan Ehtewish (17149825) Katie Lennard (5490287) Houari B. Abdesselem (14152827) Fouad Al-Shaban (17149828) Julie Decock (44558) Nehad M. Alajez (7397276) Abdelilah Arredouani (10914455) Mohamed M. Emara (9913215) Omar Albagha (8977856) Lawrence W. Stanton (6707191) Sara A. Abdulla (13902015) Jonathan M. Blackburnand (17149831) Omar M. A. El-Agnaf (8809331) |
| author2_role | author author author author author author author author author author author author author |
| author_facet | Areej Mesleh (17149822) Hanan Ehtewish (17149825) Katie Lennard (5490287) Houari B. Abdesselem (14152827) Fouad Al-Shaban (17149828) Julie Decock (44558) Nehad M. Alajez (7397276) Abdelilah Arredouani (10914455) Mohamed M. Emara (9913215) Omar Albagha (8977856) Lawrence W. Stanton (6707191) Sara A. Abdulla (13902015) Jonathan M. Blackburnand (17149831) Omar M. A. El-Agnaf (8809331) |
| author_role | author |
| dc.creator.none.fl_str_mv | Areej Mesleh (17149822) Hanan Ehtewish (17149825) Katie Lennard (5490287) Houari B. Abdesselem (14152827) Fouad Al-Shaban (17149828) Julie Decock (44558) Nehad M. Alajez (7397276) Abdelilah Arredouani (10914455) Mohamed M. Emara (9913215) Omar Albagha (8977856) Lawrence W. Stanton (6707191) Sara A. Abdulla (13902015) Jonathan M. Blackburnand (17149831) Omar M. A. El-Agnaf (8809331) |
| dc.date.none.fl_str_mv | 2023-10-16T09:00:00Z |
| dc.identifier.none.fl_str_mv | 10.3389/fnmol.2023.1222506 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/High-throughput_autoantibody_screening_identifies_differentially_abundant_autoantibodies_in_autism_spectrum_disorder/26796202 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biological sciences Genetics Biomedical and clinical sciences Clinical sciences Neurosciences autism spectrum disorder autoantibodies profiling pathways biomarker |
| dc.title.none.fl_str_mv | High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <h3>Introduction</h3><p dir="ltr">Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by defects in two core domains, social/communication skills and restricted/repetitive behaviors or interests. There is no approved biomarker for ASD diagnosis, and the current diagnostic method is based on clinical manifestation, which tends to vary vastly between the affected individuals due to the heterogeneous nature of ASD. There is emerging evidence that supports the implication of the immune system in ASD, specifically autoimmunity; however, the role of autoantibodies in ASD children is not yet fully understood.</p><h3>Materials and methods</h3><p dir="ltr">In this study, we screened serum samples from 93 cases with ASD and 28 healthy controls utilizing high-throughput KoRectly Expressed (KREX) i-Ome protein-array technology. Our goal was to identify autoantibodies with differential expressions in ASD and to gain insights into the biological significance of these autoantibodies in the context of ASD pathogenesis.</p><h3>Result</h3><p dir="ltr">Our autoantibody expression analysis identified 29 differential autoantibodies in ASD, 4 of which were upregulated and 25 downregulated. Subsequently, gene ontology (GO) and network analysis showed that the proteins of these autoantibodies are expressed in the brain and involved in axonal guidance, chromatin binding, and multiple metabolic pathways. Correlation analysis revealed that these autoantibodies negatively correlate with the age of ASD subjects.</p><h3>Conclusion</h3><p dir="ltr">This study explored autoantibody reactivity against self-antigens in ASD individuals' serum using a high-throughput assay. The identified autoantibodies were reactive against proteins involved in axonal guidance, synaptic function, amino acid metabolism, fatty acid metabolism, and chromatin binding.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Molecular Neuroscience<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fnmol.2023.1222506" target="_blank">https://dx.doi.org/10.3389/fnmol.2023.1222506</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_d162ab722dc6fc320be8d15343cb73ae |
| identifier_str_mv | 10.3389/fnmol.2023.1222506 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/26796202 |
| publishDate | 2023 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorderAreej Mesleh (17149822)Hanan Ehtewish (17149825)Katie Lennard (5490287)Houari B. Abdesselem (14152827)Fouad Al-Shaban (17149828)Julie Decock (44558)Nehad M. Alajez (7397276)Abdelilah Arredouani (10914455)Mohamed M. Emara (9913215)Omar Albagha (8977856)Lawrence W. Stanton (6707191)Sara A. Abdulla (13902015)Jonathan M. Blackburnand (17149831)Omar M. A. El-Agnaf (8809331)Biological sciencesGeneticsBiomedical and clinical sciencesClinical sciencesNeurosciencesautism spectrum disorderautoantibodiesprofilingpathwaysbiomarker<h3>Introduction</h3><p dir="ltr">Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by defects in two core domains, social/communication skills and restricted/repetitive behaviors or interests. There is no approved biomarker for ASD diagnosis, and the current diagnostic method is based on clinical manifestation, which tends to vary vastly between the affected individuals due to the heterogeneous nature of ASD. There is emerging evidence that supports the implication of the immune system in ASD, specifically autoimmunity; however, the role of autoantibodies in ASD children is not yet fully understood.</p><h3>Materials and methods</h3><p dir="ltr">In this study, we screened serum samples from 93 cases with ASD and 28 healthy controls utilizing high-throughput KoRectly Expressed (KREX) i-Ome protein-array technology. Our goal was to identify autoantibodies with differential expressions in ASD and to gain insights into the biological significance of these autoantibodies in the context of ASD pathogenesis.</p><h3>Result</h3><p dir="ltr">Our autoantibody expression analysis identified 29 differential autoantibodies in ASD, 4 of which were upregulated and 25 downregulated. Subsequently, gene ontology (GO) and network analysis showed that the proteins of these autoantibodies are expressed in the brain and involved in axonal guidance, chromatin binding, and multiple metabolic pathways. Correlation analysis revealed that these autoantibodies negatively correlate with the age of ASD subjects.</p><h3>Conclusion</h3><p dir="ltr">This study explored autoantibody reactivity against self-antigens in ASD individuals' serum using a high-throughput assay. The identified autoantibodies were reactive against proteins involved in axonal guidance, synaptic function, amino acid metabolism, fatty acid metabolism, and chromatin binding.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Molecular Neuroscience<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fnmol.2023.1222506" target="_blank">https://dx.doi.org/10.3389/fnmol.2023.1222506</a></p>2023-10-16T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3389/fnmol.2023.1222506https://figshare.com/articles/journal_contribution/High-throughput_autoantibody_screening_identifies_differentially_abundant_autoantibodies_in_autism_spectrum_disorder/26796202CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/267962022023-10-16T09:00:00Z |
| spellingShingle | High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder Areej Mesleh (17149822) Biological sciences Genetics Biomedical and clinical sciences Clinical sciences Neurosciences autism spectrum disorder autoantibodies profiling pathways biomarker |
| status_str | publishedVersion |
| title | High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder |
| title_full | High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder |
| title_fullStr | High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder |
| title_full_unstemmed | High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder |
| title_short | High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder |
| title_sort | High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder |
| topic | Biological sciences Genetics Biomedical and clinical sciences Clinical sciences Neurosciences autism spectrum disorder autoantibodies profiling pathways biomarker |